EGFR and lung carcinoma: In addition, gefitinib’s inhibition of EGFR signaling decreased the expression of the PELP1 protein, whereas EGF’s stimulation of the EGFR pathway increased PELP1’s protein expression in lung cancer cells (Wang et al., 2022).